{
    "root": "30161630-325a-4bb8-e063-6394a90a5e27",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Famotidine",
    "value": "20250311",
    "ingredients": [
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4"
        },
        {
            "name": "HYPROMELLOSES",
            "code": "3NXW29V3WO"
        },
        {
            "name": "CELLULOSE, MICROCRYSTALLINE",
            "code": "OP1R32D61U"
        },
        {
            "name": "STARCH, CORN",
            "code": "O8232NY3SJ"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2"
        },
        {
            "name": "TALC",
            "code": "7SEV7J4R1U"
        },
        {
            "name": "TITANIUM DIOXIDE",
            "code": "15FIX9V2JP"
        },
        {
            "name": "FERRIC OXIDE YELLOW",
            "code": "EX438O2MRT"
        },
        {
            "name": "FERRIC OXIDE RED",
            "code": "1K09F3G675"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X"
        },
        {
            "name": "TRIACETIN",
            "code": "XHX3C3X673"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30"
        },
        {
            "name": "POLYETHYLENE GLYCOL 3000",
            "code": "SA1B764746"
        },
        {
            "name": "POLYETHYLENE GLYCOL 4000",
            "code": "4R4HFI6D95"
        },
        {
            "name": "FAMOTIDINE",
            "code": "5QZO15J2Z8"
        }
    ],
    "indications": "Famotidine tablets are indicated in adult and pediatric patients 40 kg and greater for the treatment of: active duodenal ulcer (DU). \n                  \n                     active gastric ulcer (GU). \n                     active gastric ulcer (GU).\n                     symptomatic nonerosive gastroesophageal reflux disease (GERD). \n                     erosive esophagitis due to GERD, diagnosed by biopsy. \n                  \n                  Famotidine tablets are indicated in adults for the: \n                  \n                     treatment of pathological hypersecretory conditions (e.g., Zollinger-Ellison syndrome, multiple endocrine neoplasias). \n                     reduction of the risk of duodenal ulcer recurrence.",
    "contraindications": "Indication Recommended Dosage (2.1) Adult and Pediatric Patients 40 kg and greater Active DU 40 mg once daily; or 20 mg twice daily Active Gastric Ulcer 40 mg once daily GERD 20 mg twice daily Erosive Esophagitis 20 mg twice daily; or 40 mg twice daily Adults Pathological Hypersecretory Condition 20 mg every 6 hours; adjust to patient needs; maximum 160 mg every 6 hours Risk Reduction of DU Reoccurrence 20 mg once daily See full prescribing information for complete dosing information, including dosing in renal impairment, and recommended treatment duration. (2.1, 2.2) Administration (2.3): Take once daily before bedtime or twice daily in the morning and before bedtime with or without food.",
    "warningsAndPrecautions": "Famotidine Tablets USP, 20 mg are available as beige, round, unscored, film-coated tablets, debossed with \"5728\" on one side and “TEVA” on the other side containing 20 mg famotidine, packaged in bottles of 60 tablets.\n                  Bottles of 60: 20 mg (NDC 68645-140-59)\n                  \n                  Dispense in a well-closed, light-resistant container as defined in the USP, with a child-resistant closure (as required).\n                  Store at 20° to 25°C (68° to 77°F) [See USP Controlled Room Temperature]. Avoid storage of famotidine tablets at temperatures above 40°C (104°F).\n                  KEEP THIS AND ALL MEDICATIONS OUT OF THE REACH OF CHILDREN.",
    "adverseReactions": "Famotidine tablets are contraindicated in patients with a history of serious hypersensitivity reactions (e.g., anaphylaxis) to famotidine or other histamine-2 (H2) receptor antagonists."
}